LAURIDSEN GROUP INC has a total of 34 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are INTREXON ACTOBIOTICS N V, SHANGHAI BORONG GENE DEV CO and BIOROAD GENE DEV LTD SHANGHAI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | Mexico | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Fodder | |
#6 | Food proteins | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Strohbehn Ronald E | 20 |
#2 | Campbell Joy M | 18 |
#3 | Russell Louis E | 16 |
#4 | Borg Barton S | 15 |
#5 | Weaver Eric M | 15 |
#6 | Arthington John D | 12 |
#7 | Quigley James D Iii | 11 |
#8 | Polo Pozo Francisco Javier | 10 |
#9 | Yoder Ralph D | 8 |
#10 | Pozo Francisco Javier Polo | 5 |
Publication | Filing date | Title |
---|---|---|
EP2303291A2 | Iga and igg for reducing lung inflammation in an animal | |
EP1599227A2 | Methods of immunomodulation in animals | |
US2004146565A1 | First lipoprotein fraction and therapeutic compositions of same | |
US6995242B2 | Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof | |
WO02102487A2 | Process for preparing protein isolate from milk, whey, colostrum, and the like | |
US2003223985A1 | Globulin protein to lower cholesterol in humans | |
BR0207685A | Method for increasing the live weight of poultry, plasma food, and aqueous plasma product | |
US6749872B2 | Heme supplement and method of using same | |
EP1357942A2 | Methods and compositions for treatment of immune dysfunction disorders | |
CA2437095A1 | Methods and compositions for modulating the immune system of animals | |
US6939954B2 | Isolated bovine lgG heavy chain protein and its use as an antimicrobial | |
US7244427B2 | Isolated bovine IgG heavy chain protein and its use as an antimicrobial |